Hepatitis C Module #1: The abCs of HCV

Module One will address the epidemiology, diagnosis, and pathophysiology of HCV. Staging of HCV will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #2: Direct Acting Antivirals for the Treatment of Hepatitis C

Module Two will discuss the evolution of HCV treatments and the pharmacology of current agents. Possible drug interactions will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #3: HCV Drug Therapy Management

Module Three will address patient specific factors, treatment options, and the monitoring of HCV treatments. Pharmacist interventions will also be discussed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #4: Treatment of HCV in Special Populations, HCV Resistance, and the Future of HCV Therapy

Module Four will include appropriateness of therapy for special populations, resistance issues, and emerging treatment options. The role of the specialty pharmacist will also be addressed. This activity is available for free to NASP members. Visit the top section of www.ProCE.com/CSPE for details.

IBD: Medication and Patient Management

This activity addresses treatment goals, options for therapy, monitoring parameters and the pharmacist's role in IBD therapy management.

Incorporating the Newest CLSI Recommendations for Antimicrobial Susceptibility Testing into your Stewardship Activities

This annual webcast that provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast includes recent CLSI antimicrobial susceptibility testing updates for gram positive/gram negative bacteria and Candida species.

Infections in the Hematopoietic Cell Transplantation Setting: Improving Outcomes Through Interdisciplinary Care

This activity discusses evidence-based approaches to management of infections in the HCT setting, with a particular emphasis on interdisciplinary management.

Introduction to Diagnostic Stewardship

Topics will include an overview of diagnostic stewardship from a clinical laboratory perspective, including review of important diagnostics that have an impact on patient outcomes. A review of the linkages between diagnostics and enhancing antimicrobial stewardship will be provided.

Introduction to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Leveraging Pharmacist Expertise in Oral Anticoagulant Reversal

This activity will address the burden of major bleeding for patients on oral anticoagulants and the health-systems that treat them.